MRI in patients with pacemakers-Overview and procedural management;Kernspintomographie bei Schrittmacherpatienten: Überblick und prozedurales Management

Deutsches Arzteblatt International

Volumn 109, Issue 15, 2012, Pages 270-275

  Bovenschulte, Henning ^a   Schlüter Brust, Klaus ^a   Liebig, Thomas ^a   Erdmann, Erland ^b   Eysel, Peer ^a   Zobel, Carsten ^b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b Klinik III fur Innere Medizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EMERGENCY CARE; HEART PACING; HUMAN; IMAGE QUALITY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MEDICAL SOCIETY; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER; PATIENT MONITORING; PATIENT SAFETY; REVIEW; TREATMENT CONTRAINDICATION; UNIVERSITY HOSPITAL; ARTIFICIAL HEART PACEMAKER; DRUG CONTRAINDICATION; ELECTRIC BURN; EQUIPMENT;

BURNS, ELECTRIC; EQUIPMENT FAILURE; HUMANS; MAGNETIC RESONANCE IMAGING; PACEMAKER, ARTIFICIAL;

EID: 84865848377     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2012.0270     Document Type: Review

References (25)

1. Roguin A, Schwitter J, Vahlhaus C, et al.: Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices. Europace 2008; 10: 336-46.
2. Irnich W, Irnich B, Bartsch C, et al.: Do we need pacemakers resistant to magnetic resonance imaging? Europace 2005; 7: 353-65.
3. Sommer T, Naehle C P, Yang A, et al.: Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non-pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006; 114: 1285-92.
4. Luechinger R, Zeijlemaker VA, Pedersen EM, et al.: In vivo heating of pacemaker leads during magnetic resonance imaging. Eur Heart J 2005; 26: 376-83.
5. Roguin A, Zviman MM, Meininger GR, et al.: Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 T. Circulation 2004; 110: 475-82.
6. Luechinger R, Duru F, Zeijlemaker VA, et al.: Pacemaker reed switch behavior in 0.5, 1.5, and 3.0 Tesla magnetic resonance imaging units: are reed switches always closed in strong magnetic fields? Pacing Clin Electrophysiol 2002; 25: 1419-23.
7. Gimbel JR: Unexpected asystole during 3T magnetic resonance imaging of a pacemaker-dependent patient with a 'modern' pacemaker. Europace 2009; 11: 1241-2.
8. Gimb e l JR, Baile y SM, Tchou PJ, R uggieri PM, W i l koff BL: Strategie s for the safe magnetic resonance imaging of pacemaker-dependent patients. Pacing Clin Electrophysiol 2005; 28: 1041-6.
9. Naehle C P, Litt H, Lewalter T, Sommer T: Do we need pacemakers resistant to magnetic resonance imaging? Europace 2006; 8: 388.
10. Sommer T, Vahlhaus C, Lauck G, et al.: MR imaging and cardiac pacemakers: in-vitro evaluation and in-vivo studies in 51 patients at 0.5 T. Radiology 2000; 215: 869-79.
11. Schmiedel A, Hackenbroch M, Yang A, et al.: Magnetic resonance imaging of the brain in patients with cardiac pacemakers. Experimental and clinical investigations at 1.5 Tesla. Rofo 2005; 177: 731-44.
12. Martin E T, Coman JA, Shellock FG, et al.: Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004; 43: 1315-24.
13. Nazarian S, Roguin A, Zviman MM, et al.: Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-car-dioverter defibrillators at 1.5 tesla. Circulation 2006; 114: 1277-84.
14. Nazarian S, Hansford R, Roguin A, et al.: A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011; 155: 415-24.
15. Mollerus M, Albin G, Lipinski M, Lucca J: Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 2010; 12: 947-51.
16. Strach K, Naehle C P, Muhlsteffen A, et al.: Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace 2010; 12: 952-60.
17. Naehle C P, Meyer C, Thomas D, et al.: Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology 2008; 249: 991-1001.
18. Mollerus M, Albin G, Lipinski M, Lucca J: Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol 2008; 31: 1241-5.
19. Naehle C P, Zeijlemaker V, Thomas D, et al.: Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol 2009; 32: 1526-35.
20. Burke PT, Ghanbari H, Alexander PB, et al.: A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol 2010; 28: 59-66.
21. Naehle C P, Kreuz J, Strach K, et al.: Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pacemakers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J 2011; 161: 1096-105.
22. Gimbel JR: Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla. Pacing Clin Electrophysiol 2008; 31: 795-801.
23. Langman DA, Goldberg IB, Finn J P, Ennis DB: Pacemaker lead tip heating in abandoned and pacemaker-attached leads at 1.5 Tesla MRI. J Magn Reson Imaging 2011; 33: 426-31.
24. Wilkoff BL, Bello D, Taborsky M, et al.: Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011; 8: 65-73.
25. Junttila MJ, Fishman JE, Lopera GA, et al.: Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart 2011; 97: 1852-6.